text
stringlengths 0
1.95M
|
---|
various stock option plans. That cost is expected to be recognized during the remaining periods of 2023 and 2024. 20 Zion |
Oil & Gas, Inc. Consolidated |
Condensed Notes to Financial Statements (Unaudited) Note |
3 - Stockholders’ Equity (cont’d) D. |
Dividend Reinvestment and Stock Purchase Plan (“DSPP”) On |
March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with |
the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. |
On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration |
No. 333-193336), for which the three year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The |
Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed |
and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and |
replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336. On |
March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders |
and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly |
from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original |
Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration |
Statement on Form S-3, as thereafter amended. On |
January 13, 2015, the Company amended the Original Prospectus Supplement (“Amendment No. 3”) to provide for a unit option |
(the “Unit Option”) under the DSPP comprised of one share of Common Stock and three Common Stock purchase warrants with each |
unit priced at $ 4.00 . Each warrant afforded the participant the opportunity to purchase the Company’s Common Stock at a warrant |
exercise price of $ 1.00 . Each of the three warrants series had different expiration dates that had been extended. The |
ZNWAB warrants first became exercisable on May 2, 2016 and, in the case of ZNWAC on May 2, 2017 and in the case of ZNWAD on May 2, 2018, |
at a per share exercise price of $ 1.00 . As |
of May 2, 2017, any outstanding ZNWAB warrants expired. As |
of May 2, 2018, any outstanding ZNWAC warrants expired. On |
May 29, 2019, the Company extended the termination date of the ZNWAD Warrant by one (1) year from the expiration date of May 2, 2020 |
to May 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On |
September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, |
2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this |
extension. As |
of May 2, 2023, any outstanding ZNWAD warrants expired. On |
November 1, 2016, the Company launched a unit offering under the Company’s DSPP pursuant to which participants could purchase units |
comprised of seven shares of Common Stock and seven Common Stock purchase warrants, at a per unit purchase price of $ 10 . The warrant |
is referred to as “ZNWAE.” The |
ZNWAE warrants became exercisable on May 1, 2017 and continued to be exercisable through May 1, 2020 at a per share exercise price of |
$ 1.00 . On |
May 29, 2019, the Company extended the termination date of the ZNWAE Warrant by one ( 1 ) year from the expiration date of May 1, 2020 |
to May 1, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On |
September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two ( 2 ) years from the expiration date of May 1, |
2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this |
extension. 21 Zion |
Oil & Gas, Inc. Consolidated |
Condensed Notes to Financial Statements (Unaudited) Note |
3 - Stockholders’ Equity (cont’d) As |
of May 1, 2023, any outstanding ZNWAE warrants expired. On |
May 22, 2017, the Company launched a new unit offering. This unit offering consisted of a new combination of common stock and warrants, |
a new time period in which to purchase under the program, and a new unit price, but otherwise the same unit program features, conditions |
and terms in the Prospectus Supplement applied. The unit offering terminated on July 12, 2017. This program enabled participants to purchase |
Units of the Company’s securities where each Unit (priced at $ 250.00 each) was comprised of (i) the number of shares of Common |
Stock determined by dividing $ 250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s Common |
Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 25 shares |
of Common Stock at a warrant exercise price of $ 1.00 per share. The warrant is referred to as “ZNWAF.” All |
ZNWAF warrants became exercisable on August 14, 2017 and continued to be exercisable through August 14, 2020 at a per share exercise |
price of $ 1.00 . On |
May 29, 2019, the Company extended the termination date of the ZNWAF Warrant by one (1) year from the expiration date of August 14, 2020 |
to August 14, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this |
extension. On |
September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August |
14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned |
to this extension. As |
of August 14, 2023, any outstanding ZNWAF warrants expired. An |
Amendment No. 2 to the Prospectus Supplement (as described below) was filed on October 12, 2017. Under |
Amendment No. 2, the Company initiated another unit offering which terminated on December 6, 2017. This unit offering enabled participants |
to purchase Units of the Company’s securities where each Unit (priced at $ 250.00 each) was comprised of (i) a certain number of |
shares of Common Stock determined by dividing $ 250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s |
Common Stock as reported on the NASDAQ on the unit purchase date and (ii) Common Stock purchase warrants to purchase an additional 15 shares of Common Stock at a warrant exercise price of $ 1.00 per share. The warrant is referred to as “ZNWAG.” The warrants became exercisable on January 8, |
2018 and continue to be exercisable through January 8, 2023 at a revised per share exercise price of $ .25 . The warrant terms provide that |
if the Company’s Common Stock trades above $ 5.00 per share as the closing price for 15 consecutive trading days at any time prior |
to the expiration date of the warrant, the Company has the sole discretion to accelerate the termination date of the warrant upon providing |
60 days advanced notice to the warrant holders. 22 Zion |
Oil & Gas, Inc. Consolidated |
Condensed Notes to Financial Statements (Unaudited) Note |
3 - Stockholders’ Equity (cont’d) On |
December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January |
8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned |
to this extension. On |
February 1, 2018, the Company launched another unit offering which terminated on February 28, 2018. The unit offering consisted of Units |
of our securities where each Unit (priced at $ 250.00 each) was comprised of (i) 50 shares of Common Stock and (ii) Common Stock purchase |
warrants to purchase an additional 50 shares of Common Stock. The investor’s Plan account was credited with the number of shares |
of the Company’s Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase |
one share of Company Common Stock at a warrant exercise price of $ 5.00 . The warrant is referred to as “ZNWAH.” The |
warrants became exercisable on April 2, 2018 and continued to be exercisable through April 2, 2020 at a per share exercise price of $ 5.00 , |
after the Company, on December 4, 2018, extended the termination date of the Warrant by one ( 1 ) year from the expiration date of April |
2, 2019 to April 2, 2020. On |
May 29, 2019, the Company extended the termination date of the ZNWAH Warrant by one ( 1 ) year from the expiration date of April 2, 2020 |
to April 2, 2021. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. On |
September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two ( 2 ) years from the expiration date of April |
2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to |
this extension. As |
of April 2, 2023, any outstanding ZNWAH warrants expired. On |
August 21, 2018, the Company initiated another unit offering, and it terminated on September 26, 2018. The offering consisted of Units |
of the Company’s securities where each Unit (priced at $ 250.00 each) was comprised of (i) a certain number of shares of Common |
Stock determined by dividing $ 250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly |
traded common stock as reported on the NASDAQ on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional |
twenty-five (25) shares of Common Stock. The investor’s Plan account was credited with the number of shares of the Company’s |
Common Stock acquired under the Units purchased. Each warrant affords the investor the opportunity to purchase one share of Company Common |
Stock at a warrant exercise price of $ 1.00 . The warrant is referred to as “ZNWAJ.” The |
warrants became exercisable on October 29, 2018 and continued to be exercisable through October 29, 2020 at a per share exercise price |
of $ 1 .00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date |
of October 29, 2019 to October 29, 2020. On |
Subsets and Splits